Beavis R E, Mullany C J, Cronin K D, Scott D A, Treagus B C, Zhikun Y, Worner M J
University of Melbourne, Department of Surgery, Australia.
J Thorac Cardiovasc Surg. 1988 Jun;95(6):1059-66.
The internal mammary artery is clearly the preferred conduit for most patients undergoing coronary artery bypass grafting. However, the hemodynamic responses of this graft to vasoactive agents immediately after bypass have not been documented. We have therefore studied blood flow in the canine internal mammary artery after anastomosis to the left anterior descending artery, and its response to epinephrine, metaraminol, isoproterenol, and calcium chloride. Blood flow in the internal mammary artery clearly paralleled changes in systolic blood pressure with perfusion pressure being of prime importance in maintaining flow in the internal mammary artery. No deleterious effect of systemic vasoconstricting agents was demonstrated. We suggest that the administration of these drugs is safe in patients with internal mammary artery grafts.
对于大多数接受冠状动脉旁路移植术的患者而言,胸廓内动脉显然是首选的血管桥。然而,旁路手术后该血管桥对血管活性药物的血流动力学反应尚未见诸报道。因此,我们研究了犬胸廓内动脉与左前降支动脉吻合后其血流情况,以及对肾上腺素、间羟胺、异丙肾上腺素和氯化钙的反应。胸廓内动脉的血流明显与收缩压的变化平行,灌注压对维持胸廓内动脉的血流至关重要。未显示全身性血管收缩剂有有害作用。我们认为,对于接受胸廓内动脉血管桥移植的患者,使用这些药物是安全的。